Takeda Pharmaceutical Co. Ltd. - Change In Working Capital

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Change-In-Working-Capital" stands at 102.77 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 09/30/2022.

Takeda Pharmaceutical Co. Ltd.'s second quarter result of 21.94 Billion JPY for the item "Change In Working Capital" represents an increase of 118.26 percent compared to it's first quarter result.

Also, Takeda Pharmaceutical Co. Ltd.'s second quarter result of 21.94 Billion JPY for the item "Change In Working Capital" represents an increase of 127.27 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Takeda Pharmaceutical Co. Ltd.'s second quarter result of 102.77 Billion JPY for the item "Change In Working Capital" represents an increase of 27,015.83 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 413.03 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 413.03 Billion Japanese Yens.
The 3 year change is 25.06 Billion Japanese Yens.
The 5 year change is 2.91 Billion Japanese Yens.
The 10 year change is -171.15 Billion Japanese Yens.

The Serie's long term average value is 15.92 Billion Japanese Yens. It's latest available value, on 09/30/2025, is 86.85 Billion Japanese Yens higher, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 09/30/2024, to it's latest available value, on 09/30/2025, is +413.03 Billion.
The Serie's change in Japanese Yens from it's maximum value, on 03/31/2021, to it's latest available value, on 09/30/2025, is -210.80 Billion.